Somatostatin receptors 1 and 5 heterodimerize with epidermal growth factor receptor: Agonist-dependent modulation of the downstream MAPK signalling pathway in breast cancer cells

被引:38
|
作者
Watt, Heather L. [2 ]
Kharmate, Geetanjali D. [1 ]
Kumar, Ujendra [1 ]
机构
[1] Univ British Columbia, Fac Pharmaceut Sci, Div Pharmacol & Toxicol, Vancouver, BC V6T 1W5, Canada
[2] McGill Univ, Royal Victoria Hosp, Dept Expt Med, Fac Med, Montreal, PQ H3A 1A1, Canada
关键词
Somatostatin; Somatostatin receptors; Epidermal growth factor; Epidermal growth factor receptors; Dimerization; Extracellular signal-regulated kinase; HORMONE-RELEASING HORMONE; ESTROGEN-RECEPTOR; PROGNOSTIC VALUE; ERBB RECEPTORS; MESSENGER-RNA; EGF RECEPTOR; SUBTYPE; FACTOR-I; EXPRESSION; PROTEIN;
D O I
10.1016/j.cellsig.2008.11.012
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The role of somatostatin (SST) and epidermal growth factor (EGF) in breast cancer is undisputed: however, the molecular mechanisms underlying their antiproliferative or proliferative effects are not well understood. We initially confirmed that breast turnout tissues express all five somatostatin receptors (SSTR1-5) and four epidermal growth factor receptors (ErbB1-4). Subsequently, to gain insight into the function of SSTRs and ErbBs in oestrogen receptor (ER)-positive (MCF-7) or ER alpha-negative (MDA-MB-231) breast cancer cells, we defined SSTR1, SSTR5 and ErbB1 mRNA and protein expression in these two tumour cell lines. Consistent with previous studies showing SSTR1/SSTR5 heterodimerization and having seen cell-specific and ligand-selective alterations in receptor expression, we next elucidated whether SSTR1 and SSTR5 functionally interactwith ErbB1 using pbFRET analysis. We subsequently determined the effects of SST and EGF either alone, or in combination, on selected downstream signalling molecules such as erk1/2, p38 and JNK. Here, we showed that both SST and EGF influenced erk1/2 phosphorylation and that SST modulated the effects of EGF in a cell-specific manner. We also demonstrated agonist-, time and cell-dependent regulation of p38 phosphorylation. We further investigated modulation of Grb2, SOS, Shc, SH-PTP1 and SH-PTP2. ErbB1 adaptor proteins known to play a role in MAPK activation, Shc, Grb2 and SOS, changed in an agonist- and cell-specific manner whereas, SH-PTP1 and SH-PTP2, adaptor proteins reported to interact with SSTRs, translocated from the cytosol to membrane in a cell-specific manner following SST and/or EGF treatment. Although several previous studies have shown crosstalk between RTKs and GPCRs, there are no reports describing SSTR (GPCR) modulation of ErbBs (RTK) in breast cancer. To the best of our knowledge, this is the first report describing crosstalk/interactions between SSTRs and ErbBs. (c) 2008 Published by Elsevier Inc.
引用
收藏
页码:428 / 439
页数:12
相关论文
共 50 条
  • [41] Expression of breast cancer type 1 and its relation with expression of estrogen receptors, progesterone receptors, and human epidermal growth factor receptor 2/neu in breast carcinoma on trucut biopsy specimens
    Verma, Deepti
    Agarwal, Kiran
    Tudu, Sanjeev Kumar
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2018, 61 (01) : 31 - 38
  • [42] Identification and characterization of a negative regulatory element within the epidermal growth factor receptor gene first intron in hormone-dependent breast cancer cells
    Wilson, MA
    Chrysogelos, SA
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2002, 85 (03) : 601 - 614
  • [43] DIFFERENTIAL SIGNAL-TRANSDUCTION OF EPIDERMAL-GROWTH-FACTOR RECEPTORS IN HORMONE-DEPENDENT AND HORMONE-INDEPENDENT HUMAN BREAST-CANCER CELLS
    MUELLER, H
    LOOP, P
    LIU, R
    WOSIKOWSKI, K
    KUENG, W
    EPPENBERGER, U
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1994, 221 (02): : 631 - 637
  • [44] Hypoxia induces EGFR inhibitor resistance in lung cancer cells by upregulation of fibroblast growth factor receptor 1 (FGFR1) via MAPK pathway
    Lu, Yuhong
    Liu, Yanfeng
    Oeck, Sebastian
    Zhang, Gary J.
    Glazer, Peter M.
    CANCER RESEARCH, 2020, 80 (16)
  • [45] Epidermal growth factor-induced nuclear factor κB activation:: A major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cells
    Biswas, DK
    Cruz, AP
    Gansberger, E
    Pardee, AB
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (15) : 8542 - 8547
  • [46] microRNA-133a regulates the cell cycle and proliferation of breast cancer cells by targeting epidermal growth factor receptor through the EGFR/Akt signaling pathway
    Cui, Wenjing
    Zhang, Shuai
    Shan, Changliang
    Zhou, Li
    Zhou, Zhemin
    FEBS JOURNAL, 2013, 280 (16) : 3962 - 3974
  • [47] INCREASED EPIDERMAL GROWTH-FACTOR RECEPTOR LEVEL IN BREAST-CANCER CELLS TREATED BY 1,25-DIHYDROXYVITAMIN-D3
    FALETTE, N
    FRAPPART, L
    LEFEBVRE, MF
    SAEZ, S
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1989, 63 (1-2) : 189 - 198
  • [48] Correction: Complement inhibitor CSMD1 modulates epidermal growth factor receptor oncogenic signaling and sensitizes breast cancer cells to chemotherapy
    Chrysostomi Gialeli
    Emre Can Tuysuz
    Johan Staaf
    Safa Guleed
    Veronika Paciorek
    Matthias Mörgelin
    Konstantinos S. Papadakos
    Anna M. Blom
    Journal of Experimental & Clinical Cancer Research, 42
  • [49] ECTOPIC EXPRESSION OF EPIDERMAL GROWTH-FACTOR RECEPTORS INDUCES HORMONE INDEPENDENCE IN ZR-75-1 HUMAN BREAST-CANCER CELLS
    VANAGTHOVEN, T
    VANAGTHOVEN, TLA
    PORTENGEN, H
    FOEKENS, JA
    DORSSERS, LCJ
    CANCER RESEARCH, 1992, 52 (18) : 5082 - 5088
  • [50] Growth regulation of human colon cancer cells by epidermal growth factor and 1,25-dihydroxyvitamin D3 is mediated by mutual modulation of receptor expression
    Tong, WM
    Kállay, E
    Hofer, H
    Hulla, W
    Manhardt, T
    Peterlik, M
    Cross, HS
    EUROPEAN JOURNAL OF CANCER, 1998, 34 (13) : 2119 - 2125